A detailed history of Sonata Capital Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Sonata Capital Group Inc holds 310 shares of LLY stock, worth $260,359. This represents 0.1% of its overall portfolio holdings.

Number of Shares
310
Holding current value
$260,359
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 30, 2025

BUY
$713.71 - $898.95 $221,250 - $278,674
310 New
310 $242,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $798B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sonata Capital Group Inc Portfolio

Follow Sonata Capital Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sonata Capital Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sonata Capital Group Inc with notifications on news.